These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7959522)

  • 41. Paroxetine: a review.
    Bourin M; Chue P; Guillon Y
    CNS Drug Rev; 2001; 7(1):25-47. PubMed ID: 11420571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
    DeVane CL
    J Clin Psychiatry; 2003; 64 Suppl 18():14-9. PubMed ID: 14700450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB
    Pharmacotherapy; 1994; 14(2):127-38. PubMed ID: 8197030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.
    Holliday SM; Plosker GL
    Drugs Aging; 1993; 3(3):278-99. PubMed ID: 8324301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review of the metabolism and pharmacokinetics of paroxetine in man.
    Kaye CM; Haddock RE; Langley PF; Mellows G; Tasker TC; Zussman BD; Greb WH
    Acta Psychiatr Scand Suppl; 1989; 350():60-75. PubMed ID: 2530793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required.
    Nevels RM; Gontkovsky ST; Williams BE
    Psychopharmacol Bull; 2016 Mar; 46(1):77-104. PubMed ID: 27738376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Paroxetine: pharmacokinetics and pharmacodynamics].
    Hiemke C
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():2-8. PubMed ID: 7959522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    Tulloch IF; Johnson AM
    J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.
    Nemeroff CB
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):10S-17S. PubMed ID: 8106649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paroxetine: a pharmacological review.
    Johnson AM
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():15-24. PubMed ID: 1331230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH
    Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.